PMN
|
If Aducanumab doesn't get approved for Biogen, they would lose more than...
|
PMN
|
The serology test results of identifying the neutralizing antibodies is still...
|
PMN
|
Abbot Antigen test has a sensitivity of 97.1% and specificity of 98.5%. It...
|
PMN
|
I thought Anthony's expertise was to get a large number of investors to...
|
PMN
|
30% SP increase with 1.9 million shares traded today and we closed at the...
|
PMN
|
If people are losing antibodies every two months, will they have to get...
|
PMN
|
The PDUFA date is March 7, 2021 for FDA Approval of Aducanumab. It's not...
|
PMN
|
Seems like someone didnt like the presentation, SP continues to fall. It'...
|
PMN
|
Forget the 38 cents which never happened recently, most people here including...
|
PMN
|
In less than a couple weeks from now, it will be three months since they...
|
PMN
|
Great valuation at $5.50. A potential upside of almost 3000%. Lets try to get...
|
PMN
|
Promis neurosciences posted this article on their Twitter feed. They...
|
PMN
|
Only 60k shares traded today. Lowest volume in months. Maybe everyone is on...
|
PMN
|
Cash on hand as at June 30th is $1.296 million which probably lasts two to...
|
PMN
|
They reduced some expenses in Q2 and received $1.2 million in May from the...
|
PMN
|
TORONTO and CAMBRIDGE, Mass., Aug. 13, 2020 (GLOBE NEWSWIRE) -- ProMIS...
|
PMN
|
When they said "near-term diagnostic revenue", I like to assume...
|
PMN
|
You might be right. With a volume of almost a million yesterday and 800k on...
|
PMN
|
We are at the pre-covid news spike to 30 cents. There is so much potential...
|
T.LUC
|
Would you know Nyoni what the blue and pink diamonds sold for? I can't...
|